Evidence map›Paper›PMID 26781215›Full record

ReviewSAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance2016

Zimbabwe's national AIDS levy: A case study.

Nisha Bhat, Peter H Kilmarx, Freeman Dube, Albert Manenji, Medelina Dube, Tapuwa Magure

Abstract readReview
In one paragraph

Review in SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Women Living with HIV in Zimbabwe: Their Stigma-Related Emotional Life and Sense of Self.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. HIV: from exceptionalism to endgame.Lancet (London, England) · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nisha Bhata is an International Experience and Technical Assistance Fellow affiliated to US Centers for Disease Control and Prevention , Harare.
Peter H Kilmarxb MD, is a medical epidemiologist affiliated to US Centers for Disease Control and Prevention , Harare . Email: peter.kilmarx@nih.gov.
Freeman Dubed is a Research and Documentation Coordinator affiliated to National AIDS Council of Zimbabwe , Harare.
Albert Manenjie is a Finance Director affiliated to National AIDS Council of Zimbabwe , Harare.
Medelina Dubef is a Communications Director affiliated to National AIDS Council of Zimbabwe , Harare.
Tapuwa Magureg MBcHB, MPH, MBA, is a Chief Executive Officer affiliated to National AIDS Council of Zimbabwe , Harare.

Funding

Intramural CDC HHS CC999999PEPFAR
6 · The paper itself

Abstract

backgroundWe conducted a case study of the Zimbabwe National AIDS Trust Fund ('AIDS Levy') as an approach to domestic government financing of the response to HIV and AIDS.

methodsData came from three sources: a literature review, including a search for grey literature, review of government documents from the Zimbabwe National AIDS Council (NAC), and key informant interviews with representatives of the Zimbabwean government, civil society and international organizations.

findingsThe literature search yielded 139 sources, and 20 key informants were interviewed. Established by legislation in 1999, the AIDS Levy entails a 3% income tax for individuals and 3% tax on profits of employers and trusts (which excluded the mining industry until 2015). It is managed by the parastatal NAC through a decentralized structure of AIDS Action Committees. Revenues increased from inception to 2006 through 2008, a period of economic instability and hyperinflation. Following dollarization in 2009, annual revenues continued to increase, reaching US$38.6 million in 2014. By policy, at least 50% of funds are used for purchase of antiretroviral medications. Other spending includes administration and capital costs, HIV prevention, and monitoring and evaluation. Several financial controls and auditing systems are in place. Key informants perceived the AIDS Levy as a 'homegrown' solution that provided country ownership and reduced dependence on donor funding, but called for further increased transparency, accountability, and reduced administrative costs, as well as recommended changes to increase revenue.

conclusionsThe Zimbabwe AIDS Levy has generated substantial resources, recently over US$35 million per year, and signals an important commitment by Zimbabweans, which may have helped attract other donor resources. Many key informants considered the Zimbabwe AIDS Levy to be a best practice for other countries to follow.

Indexed as

Financing, GovernmentNational Health ProgramsHealth Services Needs and DemandHIV InfectionsHumansZimbabweAIDSfinancement des soins de santéhealth care financingHIVle sida,le VIHle ZimbabweZimbabwe

Identifiers

PMID26781215
PMCPMC4762022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.